Literature DB >> 11264736

Hepatitis B surface antigen variants in vaccinees, blood donors and an interferon-treated patient.

S Seddigh-Tonekaboni1, W L Lim, B Young, J L Hou, J Waters, K X Luo, H C Thomas, P Karayiannis.   

Abstract

Variants of hepatitis B virus (HBV), with amino acid substitutions in the major antigenic "a" determinant of hepatitis B surface antigen (HBsAg), have been described mainly in vaccinated children. In the present study in addition to vaccinated children, we have investigated Chinese blood donors positive for anti-HBc alone, and a patient with continuing liver disease after interferon-induced seroconversion to anti-HBs. Variants were detected in two of four children with break-through infections. One child had a double mutation (P142S and G145R) and the other a G145A substitution. Three of seven anti-HBc positive Chinese blood donors had a T131I substitution, whilst the interferon-treated patient had a treble amino acid substitution (P142S, G145R and N146D). The present results indicate that HBsAg variants may exist in individuals other than vaccinated children.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11264736     DOI: 10.1046/j.1365-2893.2001.00275.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  12 in total

1.  HBV genotypes and drug resistance mutations in antiretroviral treatment-naive and treatment-experienced HBV-HIV-coinfected patients.

Authors:  Timothy Na Archampong; Ceejay L Boyce; Margaret Lartey; Kwamena W Sagoe; Adjoa Obo-Akwa; Ernest Kenu; Jason T Blackard; Awewura Kwara
Journal:  Antivir Ther       Date:  2016-05-11

2.  Hepatitis B surface antigen variants in voluntary blood donors in Nanjing, China.

Authors:  Yang Yong-Lin; Fu Qiang; Zhang Ming-Shun; Cai Jie; Ma Gui-Ming; Huang Zu-Hu; Cai Xu-Bing
Journal:  Virol J       Date:  2012-04-14       Impact factor: 4.099

3.  Hepatitis B surface antigen variant with multiple mutations in the a determinant in an agammaglobulinemic patient.

Authors:  Alexandra Alexopoulou; Gerasimos Baltayiannis; Saffie Jammeh; Jenny Waters; Spyros P Dourakis; Peter Karayiannis
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

Review 4.  Clinical significance of hepatitis B surface antigen mutants.

Authors:  Nicola Coppola; Lorenzo Onorato; Carmine Minichini; Giovanni Di Caprio; Mario Starace; Caterina Sagnelli; Evangelista Sagnelli
Journal:  World J Hepatol       Date:  2015-11-28

5.  Functional analysis of 'a' determinant mutations associated with occult HBV in HIV-positive South Africans.

Authors:  Eleanor A Powell; Ceejay L Boyce; Maemu P Gededzha; Selokela G Selabe; M Jeffrey Mphahlele; Jason T Blackard
Journal:  J Gen Virol       Date:  2016-03-31       Impact factor: 3.891

Review 6.  Clinical implications of hepatitis B virus mutations: recent advances.

Authors:  Ivana Lazarevic
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

7.  Infection with hepatitis B virus carrying novel pre-S/S gene mutations in female siblings vaccinated at birth: two case reports.

Authors:  Ming-Wei Lai; Christopher S-H Yeh; Chau-Ting Yeh
Journal:  J Med Case Rep       Date:  2010-06-23

8.  Hepatitis B virus S gene escape mutants.

Authors:  Michael A Purdy
Journal:  Asian J Transfus Sci       Date:  2007-07

9.  Temporal trend of hepatitis B surface mutations in the post-immunization period: 9 years of surveillance (2005-2013) in eastern China.

Authors:  Bingyu Yan; Jingjing Lv; Yi Feng; Jiaye Liu; Feng Ji; Aiqiang Xu; Li Zhang
Journal:  Sci Rep       Date:  2017-07-27       Impact factor: 4.379

10.  Occult HBV Infection May Be Transmitted through Close Contact and Manifest as an Overt Infection.

Authors:  Li-Ping Hu; De-Ping Liu; Qin-Yan Chen; Tim J Harrison; Xiang He; Xue-Yan Wang; Hai Li; Chao Tan; Qing-Li Yang; Kai-Wen Li; Zhong-Liao Fang
Journal:  PLoS One       Date:  2015-10-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.